Recursion Pharmaceuticals (RXRX) Net Cash Flow (QoQ) (2020 - 2026)
Recursion Pharmaceuticals (RXRX) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200.26% |
| Dec 31, 2025 | -35.56% |
| Sep 30, 2025 | 751.62% |
| Jun 30, 2025 | 115.64% |
| Mar 31, 2025 | -157.83% |
| Dec 31, 2024 | 460.62% |
| Sep 30, 2024 | -126.78% |
| Jun 30, 2024 | 285.91% |
| Mar 31, 2024 | -2,421.84% |
| Dec 31, 2023 | 120.99% |
| Sep 30, 2023 | 70.33% |
| Jun 30, 2023 | 14.34% |
| Mar 31, 2023 | -181.18% |
| Dec 31, 2022 | 12,019.10% |
| Sep 30, 2022 | 101.44% |
| Jun 30, 2022 | -124.25% |
| Mar 31, 2022 | 303.25% |
| Dec 31, 2021 | 53.95% |
| Sep 30, 2021 | -156.16% |
| Jun 30, 2021 | 982.32% |